Antioxidative Potentials of Incretin-Based Medications: A Review of Molecular Mechanisms

Glucagon-like peptide 1 receptor agonists and dipeptidyl-peptidase 4 inhibitors are medications used for managing diabetes, mimicking the metabolic effects of incretin hormones. Recent evidence suggests that these medications have antioxidative potentials in the diabetic milieu. The pathophysiology...

Descripción completa

Detalles Bibliográficos
Autores principales: Yaribeygi, Habib, Maleki, Mina, Sathyapalan, Thozhukat, Jamialahmadi, Tannaz, Sahebkar, Amirhossein
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8099522/
https://www.ncbi.nlm.nih.gov/pubmed/34007411
http://dx.doi.org/10.1155/2021/9959320

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8099522/
https://www.ncbi.nlm.nih.gov/pubmed/34007411
http://dx.doi.org/10.1155/2021/9959320

Ejemplares similares